Extracellular
single-cell recording techniques were employed to study the mechanism of action of repeated oral clozapine administration on the in viva spontaneous activity of substantia nigra (A9) and ventral tegmental area (AlO) dopamine (DA)-containing neurons in the rat. Clozapine was observed to affect DA neurons differentially within these two regions when compared to haloperidol. Acute treatment (1 hr) with both drugs increased the number of spontaneously firing neurons in both A9 and AlO. Chronic (21 day) treatment with haloperidol decreased the number of cells encountered in both regions, whereas repeated treatment with clozapine reduced the number of DA cells per track only in AlO. In all cases, the silent DA neurons were inferred to be in a state of depolarization inactivation since they could be induced to discharge normally by the microiontophoretic application of the inhibitory neurotransmitter r-aminobutyric acid. These effects were not due to an effect of chloral hydrate anesthesia since they were also observed in gallamine-paralyzed, artificially respired animals. Chronic co-administration with haloperidol of either an anticholinergic (trihexyphenidyl) or the cu,-norepinephrine (NE) receptor antagonist, prazosin, but not an as-NE antagonist, RX781094, resulted in a differential effect on A9 and A10 DA neurons identical to that observed with repeated clozapine administration alone. Thus, chronic treatment with these combinations of drugs resulted in the depolarization inactivation of only A10 cells. These data suggest that anticholinergic and/or cY,-NE-blocking properties of clozapine may, in part, mediate its differential effects on A9 and A10 midbrain DA neurons. In the past few years many basic studies have examined the actions of acute and chronic dopamine (DA) receptor antagonist (i.e., antipsychotic drug (APD)) administration on DA neuronal systems This work has been stimulated, at least in part, by the fact that APDs represent the primary pharmacological treatment for the major symptoms of psychosis, In 1978, it was shown (using singleunit extracellular recording techniques) that, whereas the acute administration of an APD increased the number of spontaneously active DA neurons within the substantia nigra (A9), chronic treatment markedly decreased the number of cells encountered (Bunney and Grace, 1978) . This reduction in the number of spontaneously firing DA neurons in chronically treated animals was shown to be due to the induction of a state of tonic depolarization (i.e., depolarization inactivation; Bunney and Grace, 1978; Chiodo and Bunney, 1983a) . Thus, these inactive DA neurons could be made to discharge in a normal fashion by the microiontophoretic application of the inhibitory neurotransmitter, r-aminobutyric acid (GABA) but not the excitatory amino acid, glutamate. Subsequently, it was shown that typical APDs (i.e., those antipsychotic drugs associated with a high incidence of extrapyramidal side effects such as haloperidol or chlorpromazine) produce this acute increase in the number of active DA neurons observed but, when given chronically, they inactivate these cells in both A9 and the ventral tegmental area (AIO) (Chiodo and Bunney, 1983a; White and Wang, 1983) . In contrast, atypical APDs (those associated with a low incidence of side effects such as clozapine (CLZ) produced a different pattern of response. Although both A9 and A10 had a similar effect acutely, only A10 DA cells (i.e., not A9 neurons) were inactivated after chronic treatment (Chiodo and Bunney, 1983a; White and Wang, 1983; Chiodo et al., 1984) .
In the present series of experiments we have utilized this differential response of A9 and Al 0 neurons to typical and atypical APDs as a means to further characterize the mode of action of CLZ on midbrain DA systems. Obtaining an understanding of the mode of action of CLZ within the central nervous system is considered important for at least two reasons. First, since the use of this compound is associated with a markedly reduced incidence of extrapyramidal side effects (including tardive dyskinesia), it is hoped that elucidating the mechanism of action of CLZ upon DA neurons will aid in the development of new APDs with low side effect potential. Second, comparing the sites of action of typical and atypical APDs may allow us to find the difference between the neuronal elements involved in clinical efficacy and those involved in side effect induction.
Previous work has suggested that the anticholinergic and possibly the cu-noradrenergic (NE) blocking properties of CLZ may underlie the relative inability of this drug to induce extrapyramidal reactions (Bartholini et al., 1972; Anden and Stock, 1973; Burki et al., 1974; Miller and Hiley, 1974; Snyder et al., 1974; Marco et al., 1976; McMillan and Shore, 1978; Pelham and Munsat, 1979; Souto et al., 1979; Racagni et al., 1980) . For this reason, we combined the anticholinergic drug trihexiphenidyl (Artane) or the al-NE antagonist prazosin with typical APDs in an attempt to produce an effect on the number of spontaneously firing DA cells in A9 and A10 similar to that produced by CLZ. The (Y~-NE blocker RX781094 (Idazoxan) was also tested. Once paralyzed, the halothane was discontinued and recordings were started 30 min later. In the paralyzed anrmals expired carbon dioxide was monitored with a Harvard COn analyzer and maintained between 3.5 and 4.0%. No difference in the number of cells per track or in the effects of drug administration were noted between the chloral hydrate and paralyzed groups. The experimenter was always blind with respect to the treatment condition of the animal. Body temperature was monitored and maintained at 36 to 37°C. Once in the stereotaxic unit, the scalp was reflected and the skull overlying both the substantia nigra (A9, anterior 1,750 to 2,580 pm, lateral 1,700 to 2,100 pm; Konig and Klippel, 1974) and the ventral tegmental area (Al 0, anterior 1,610 to 2,420 pm, lateral 100 to 500 pm) was removed. Extracellular neuronal activity was monitored using a single-barrel micropipette (overall trp diameter <I pm) filled with 2 M NaCl containing 2% pontamine sky blue dye (in vitro impedance at 135 Hz, 3 to 8 megohms).
Single-unit activity was recorded through a high input impedance amplifier (bandpass settrngs: 100 Hz to 2 kHz) the output of which was led Into an analogue oscilloscope, audio monitor, and window discriminator.
The amplifier input was also digitized at rates of 5 to 500 hsec point (4,096 points, 12 bit precision) by a Nicolet Explorer Ill digital oscilloscope and stored on floppy discs. Spontaneously active DA neurons within both the A9 and A10 areas were counted by lowering the recording micropipette through a stereotaxically defined block of tissue (120,000 brn') which could be reproducibly located from animal to animal (Chiodo and Bunney, 1983a) . Twelve electrode penetrations were made in each region. Each electrode track was separated from every other track by 200 pm, and the sequence of these tracks was kept constant. Only electrophysiologically identrfred (see Bunney et al., 1973; Grace and Bunney, 1983 ) DA neurons were sampled. Antidromic activation.
In some experiments, DA neurons within the A10 region were antidromically activated from the prefrontal cortex as previously described (Chiodo et al., 1984) . Concentric bipolar stimulating electrodes (SNE-100, David Kopf Instruments)
were stereotaxically placed in the region of the prefrontal cortex (anterior 9,650 to 11,050 pm, lateral 200 to 1,000 Frn; Konig and Klippel, 1974) . Constant current square wave pulses (0.2 to 2.5 mA; 300 to 500 psec duration) were delivered by a digital pulse generator (Series 800, World Precision Instruments) throuah a stimulus isolation unit (model 850A, World Precision Instruments).
Neurons were considered antidromrcally activated when the following criteria were met: (7 ) one antidromic spike was elicited per stimulus; (2) a fixed latency existed for the stimulusinduced actron potential; (3) the antidromic spike followed stimulations up to 50 Hz; and (4) 
Results
Effects of typical and atypical neuroleptics on the population response of midbrain DA-containing neurons. In control animals the mean number of DA cells per track in the A9 and A10 regions was 0.80 and 0.82, respectively (Fig. 1) . The acute treatment with either CLZ, HAL, or MES significantly increased the number of ceils per track in both of these regions. The mean number of cells per track for the acute HAL group was 1.76 in A9 and AIO, 1.76 and 1.72 (respectively) for acute CLZ, and 1.72 and 1.79 (respectively) for acute MES animals (Fig. 1) . On day 21 of continuous drug administration, there were significantly fewer cells per track in both regions in the animals receiving HAL but an increase in the number of active cells in A9 and a decrease in A10 in both the CLZ and MES-treated groups.
Effects of anticholinergic co-administration with HAL. A dose of 1 mg/kg of the anticholinergic ART was employed in these studies. This dose was picked because oral administration of this amount of ART was observed to markedly decrease the excitatory effects of microiontophoretically applied acetylcholine on CA1 hippocampal pyramidal neurons (N = 8; Fig. 2 ). Although neither acute nor chronic treatment with ART alone altered the number of cells per track in either region (relative to control), ART did affect the response to HAL when administered concurrently. Thus, although there was an increased number of cells per track in the acute HAL + ART animals in both areas, chronic treatment with this combination of drugs induced a decrease in the number of active DA neurons within the A10 region but not the A9 area (Fig. 1) .
Effect of a-NE antagonist co-administration with HAL. Acute treatment with the al-NE antagonist PRAZ had no effect on the number of active DA neurons encountered in A10 but significantly increased the number of cells per track observed in A9. In contrast, chronic treatment with PRAZ did not alter the number of cells per track in either area. When PRAZ and HAL were co-administered acutely, there was once again an increase in the number of spontaneously firing DA neurons in both regions. On day 21 of repeated administration of both drugs, there was a significant decrease in the number of cells per track in A10 but an increase in the number of active DA neurons in A9 (Fig. 1 ). This increase was no different from that observed with acute HAL alone, CLZ alone, or PRAZ + HAL.
Acute administration of the (Y*-NE blocker IDZ alone had no effect in A10 but produced a significant elevation in the number of DA neurons observed in A9. The number of DA cells per track in chronic IDZ treatment was not different from control values. Moreover, IDZ did not alter either the increase in cells per track produced by HAL acutely or the decrease in the number of active DA neurons normally induced by chronic HAL administration in either A9 or AlO. Thus, qualitatively similar results were observed between the acute HAL and HAL + IDZ groups as well as between the chronic HAL and HAL + IDZ groups.
Effects of anesthetic. No effect of chloral hydrate anesthetic was noted in this study. Approximately one-half of each of the following groups was sampled in gallamine-paralyzed animals: acute CLZ (n = 6 of 14) chronic CLZ (7 of 15) acute HAL (5 of lo), chronic HAL (9 of 21) and chronic MES (4 of 10). Moreover, we again have examined whether or not some of the A10 DA neurons, which were still active in the 21 -day HAL group, might in fact be mesoprefrontal DA cells. It has previously been suggested that these DA cells are devoid of synthesis-modulating nerve terminal, and somatodendritic autoreceptors (Chiodo et al., 1984) were demonstrated to be largely still spontaneously active in animals receiving chronic APDs (Chiodo and Bunney, 1983a; Chiodo et al., 1984) . However, these latter studies were carried out in chloral hydrate-anesthetized animals. In the present set of experiments, 8 of IO spontaneously active A10 DA neurons, which were found in animals that had received HAL for 21 consecutive days, were antidromically activated from the prefrontal cortex of gallamine-paralyzed animals (N = 4). These antidromitally activated cells had fixed conduction latencies of 18.2 to 26.5 msec. Given a straight-line distance between the recording micropipette and the stimulating electrode tips of 9.0 to 11 .O mm, these values correspond to an estimated conduction velocity of approximately 0.5 mm/set.
The silent DA neurons in gallamine-paralyzed animals which had been treated for 21 days with either HAL or CLZ were again shown to be in a state of depolarization inactivation. Neurons in the A10 region of both chronic HAL (N = 8) and chronic Cl-Z (N = 7) could be activated by the microiontophoretic application of the normally inhibitory substance, GABA (1 to 5 nA, Fig. 3 ). As observed in chloral hydrate-anesthetized animals (Chiodo and Bunney, 1983a), these GABA-activated neurons first began to fire rapidly and to display relatively small amplitude action potentials. As the GABA ejection continued, the discharge rate slowed (i.e., the interspike interval increased) and the action potential amplitude increased. When GABA iontophoresis was terminated, these neurons increased their rate and their amplitude decreased until it was no longer distinguishable from the background noise. Glutamate microiontophoresis onto the same neurons had no effect.
Discussion
The present series of experiments confirms and extends earlier reports (Chiodo and Bunney, 1983a; White and Wang, 1983) which demonstrate that typical and atypical APDs have different effects on the population response of A9 and A10 DA-containing neurons in the rat. Thus, the typical APDs (e.g., HAL) produce a state of depolarization inactivation of both A9 and Al 0 neurons when administered repeatedly for 21 days, whereas the atypical APDs (e.g., CLZ and MES) inactivate only Al 0 DA neurons upon chronic administration. This response is not seen when either typical or atypical APDs are given acutely or following either the acute or chronic administration of inactive isomers of DA antagonists or antidepres- (Anden and Stock, 1973; Miller and Hiley, 1974; Snyder et al., 1974; Marco et al., 1976; Pelham and Munsat, 1979; Racagni et al., 1980) we examined whether the co-administration of the anticholinergic com- GABA Figure 3 . Oscillograph tracing showing the typical response of a "silent" A10 DA neuron to microiontophoretically applied GABA (2 nA). This cell was sampled In a gallamine-paralyzed animal which had been treated with CLZ (10 mg/kg, p.o.) for 21 consecutive days. After a short delay, GABA caused the extracellular actron potential of this single neuron to appear out of the background noise. Continued ejection resulted first in a decrease in activity (action potential amplitude increased and duration decreased) and then total inhibition of the cell's activity. When the GABA is turned off, the rate markedly increases (amplrtude decreases and duration increases) until the action potential can no longer be discerned above the background noise. (The changes in action potential duration are not visible due to the chart speed employed.)
ART
The alterations in action potential amplitude and duration are identical to those observed in our previous studies of the effects of repeated APD administration on the activity of A9 and A10 DA cells (Bunney and Grace, 1978; Chiodo and Bunney, 1983a 
